Kelesidis Theodoros, Mastoris Ioannis, Metsini Aliki, Tsiodras Sotirios
4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, 1 Rimini Street, GR-12462 Haidari, Athens, Greece.
BMC Infect Dis. 2014 Nov 28;14:321. doi: 10.1186/1471-2334-14-321.
Patients with severe viral infections are often hospitalized in intensive care units (ICUs) and recent studies underline the frequency of viral detection in ICU patients. Viral infections in the ICU often involve the respiratory or the central nervous system and can cause significant morbidity and mortality especially in immunocompromised patients. The mainstay of therapy of viral infections is supportive care and antiviral therapy when available. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host proteins that regulate immunity and are involved in the viral life cycle. These novel treatments need to be further validated in animal and human randomized controlled studies.
患有严重病毒感染的患者通常在重症监护病房(ICU)住院,最近的研究强调了在ICU患者中检测到病毒的频率。ICU中的病毒感染通常累及呼吸道或中枢神经系统,尤其在免疫功能低下的患者中可导致显著的发病率和死亡率。病毒感染治疗的主要方法是支持治疗以及在有可用药物时进行抗病毒治疗。对病毒感染分子机制的深入了解为发现新的抗病毒药物提供了巨大潜力,这些药物靶向病毒蛋白或调节免疫并参与病毒生命周期的宿主蛋白。这些新型治疗方法需要在动物和人类随机对照研究中进一步验证。